Cigna Group at Wolfe Research Healthcare Conference Transcript
Ralph in IR is out there, somewhere. Thanks, Ralph, all for being here. Why don't we -- obviously, a lot to talk about, but I thought I'd give Brian a couple of minutes to kind of give us a state of the union kind of coming out of the third quarter and into '24, and then we'll do -- we'll fill up the rest with plenty of Q&A. Brian?
Thanks, Justin. I appreciate you and the Wolfe team hosting us here today.
We reported our third quarter results about 10 days ago. And if you didn't see, we had another strong quarter. Really all of our critical metrics were in line or better than expectations. So we're really pleased to deliver another strong quarterly performance.
Our EPS was a bit ahead of our expectations as was our revenue. And EPS, our performance was driven by our Cigna Healthcare business, in particular, and specifically within that, the Cigna Healthcare U.S. Commercial medical care ratio came in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |